 | • レポートコード：20QY06-04948 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、肝細胞増殖因子のグローバル市場について種類別（タイプI、タイプII）、用途別（腫瘍学、循環器、中枢神経系、血液疾患、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・肝細胞増殖因子市場の概要 ・世界の主要地域別肝細胞増殖因子市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肝細胞増殖因子市場規模2015-2026：種類別（タイプI、タイプII） ・世界の肝細胞増殖因子市場規模2015-2026：用途別（腫瘍学、循環器、中枢神経系、血液疾患、その他） ・肝細胞増殖因子の北米市場規模2015-2020 ・肝細胞増殖因子のヨーロッパ市場規模2015-2020 ・肝細胞増殖因子の中国市場規模2015-2020 ・肝細胞増殖因子の日本市場規模2015-2020 ・肝細胞増殖因子の東南アジア市場規模2015-2020 ・肝細胞増殖因子のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ViroMed、AnGes MG、M3 Biotechnology、AVEO Pharmaceuticals、Molecular Partners、Yooyoung Pharm、F-star、Galaxy Biotech、Kringle Pharma） ・肝細胞増殖因子の製造コスト分析 ・販売チャネル、流通業者、顧客 ・肝細胞増殖因子の市場動向・機会・課題 ・調査の結論 |
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
Market Analysis and Insights: Global Hepatocyte Growth Factor Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hepatocyte Growth Factor market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hepatocyte Growth Factor industry.
Based on our recent survey, we have several different scenarios about the Hepatocyte Growth Factor YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 48 million in 2019. The market size of Hepatocyte Growth Factor will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Hepatocyte Growth Factor Scope and Market Size
The global Hepatocyte Growth Factor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatocyte Growth Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hepatocyte Growth Factor market is segmented into
Type I
Type II
Segment by Application, the Hepatocyte Growth Factor market is segmented into
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
The Hepatocyte Growth Factor market is analysed and market size information is provided by regions (countries). Segment by Application, the Hepatocyte Growth Factor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepatocyte Growth Factor Market Share Analysis
Hepatocyte Growth Factor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatocyte Growth Factor business, the date to enter into the Hepatocyte Growth Factor market, Hepatocyte Growth Factor product introduction, recent developments, etc.
The major vendors covered:
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
1 Hepatocyte Growth Factor Market Overview
1.1 Hepatocyte Growth Factor Product Scope
1.2 Hepatocyte Growth Factor Segment by Type
1.2.1 Global Hepatocyte Growth Factor Sales by Type (2020-2026)
1.2.2 Type I
1.2.3 Type II
1.3 Hepatocyte Growth Factor Segment by Application
1.3.1 Global Hepatocyte Growth Factor Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Hepatocyte Growth Factor Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hepatocyte Growth Factor Sales Growth Rate (2015-2026)
1.4.2 Global Hepatocyte Growth Factor Revenue and Growth Rate (2015-2026)
1.4.3 Global Hepatocyte Growth Factor Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hepatocyte Growth Factor Industry Impact
1.5.1 How the Covid-19 is Affecting the Hepatocyte Growth Factor Industry
1.5.1.1 Hepatocyte Growth Factor Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hepatocyte Growth Factor Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hepatocyte Growth Factor Players to Combat Covid-19 Impact
2 Hepatocyte Growth Factor Estimate and Forecast by Region
2.1 Global Hepatocyte Growth Factor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hepatocyte Growth Factor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hepatocyte Growth Factor Sales Market Share by Region (2015-2020)
2.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Region (2015-2020)
2.3 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hepatocyte Growth Factor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hepatocyte Growth Factor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hepatocyte Growth Factor Estimates and Projections (2015-2026)
2.4.2 Europe Hepatocyte Growth Factor Estimates and Projections (2015-2026)
2.4.3 China Hepatocyte Growth Factor Estimates and Projections (2015-2026)
2.4.4 Japan Hepatocyte Growth Factor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hepatocyte Growth Factor Estimates and Projections (2015-2026)
2.4.6 India Hepatocyte Growth Factor Estimates and Projections (2015-2026)
3 Global Hepatocyte Growth Factor Competition Landscape by Players
3.1 Global Top Hepatocyte Growth Factor Players by Sales (2015-2020)
3.2 Global Top Hepatocyte Growth Factor Players by Revenue (2015-2020)
3.3 Global Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatocyte Growth Factor as of 2019)
3.4 Global Hepatocyte Growth Factor Average Price by Company (2015-2020)
3.5 Manufacturers Hepatocyte Growth Factor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hepatocyte Growth Factor Players (Opinion Leaders)
4 Global Hepatocyte Growth Factor Market Size by Type
4.1 Global Hepatocyte Growth Factor Historic Market Review by Type (2015-2020)
4.1.1 Global Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
4.1.2 Global Hepatocyte Growth Factor Revenue Market Share by Type (2015-2020)
4.1.3 Global Hepatocyte Growth Factor Price by Type (2014-2020)
4.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hepatocyte Growth Factor Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Type (2021-2026)
4.2.3 Global Hepatocyte Growth Factor Price Forecast by Type (2021-2026)
5 Global Hepatocyte Growth Factor Market Size by Application
5.1 Global Hepatocyte Growth Factor Historic Market Review by Application (2015-2020)
5.1.1 Global Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
5.1.2 Global Hepatocyte Growth Factor Revenue Market Share by Application (2015-2020)
5.1.3 Global Hepatocyte Growth Factor Price by Application (2015-2020)
5.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hepatocyte Growth Factor Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatocyte Growth Factor Price Forecast by Application (2021-2026)
3 North America Hepatocyte Growth Factor Market Facts & Figures
3.2 North America Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
3.3 North America Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
3.4 North America Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
4 Europe Hepatocyte Growth Factor Market Facts & Figures
4.2 Europe Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
4.3 Europe Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
4.4 Europe Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
5 China Hepatocyte Growth Factor Market Facts & Figures
5.2 China Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
5.3 China Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
5.4 China Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
6 Japan Hepatocyte Growth Factor Market Facts & Figures
6.2 Japan Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
6.3 Japan Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
6.4 Japan Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
7 Southeast Asia Hepatocyte Growth Factor Market Facts & Figures
7.2 Southeast Asia Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
8 India Hepatocyte Growth Factor Market Facts & Figures
8.2 India Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
8.3 India Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
8.4 India Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hepatocyte Growth Factor Business
12.1 ViroMed
12.1.1 ViroMed Hepatocyte Growth Factor Corporation Information
12.1.2 ViroMed Hepatocyte Growth Factor Business Overview and Total Revenue
12.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 ViroMed Hepatocyte Growth Factor Products Offered
12.1.5 ViroMed Recent Development
12.2 AnGes MG
12.2.1 AnGes MG Hepatocyte Growth Factor Corporation Information
12.2.2 AnGes MG Hepatocyte Growth Factor Business Overview and Total Revenue
12.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AnGes MG Hepatocyte Growth Factor Products Offered
12.2.5 AnGes MG Recent Development
12.3 M3 Biotechnology
12.3.1 M3 Biotechnology Hepatocyte Growth Factor Corporation Information
12.3.2 M3 Biotechnology Hepatocyte Growth Factor Business Overview and Total Revenue
12.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 M3 Biotechnology Hepatocyte Growth Factor Products Offered
12.3.5 M3 Biotechnology Recent Development
12.4 AVEO Pharmaceuticals
12.4.1 AVEO Pharmaceuticals Hepatocyte Growth Factor Corporation Information
12.4.2 AVEO Pharmaceuticals Hepatocyte Growth Factor Business Overview and Total Revenue
12.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Products Offered
12.4.5 AVEO Pharmaceuticals Recent Development
12.5 Molecular Partners
12.5.1 Molecular Partners Hepatocyte Growth Factor Corporation Information
12.5.2 Molecular Partners Hepatocyte Growth Factor Business Overview and Total Revenue
12.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Molecular Partners Hepatocyte Growth Factor Products Offered
12.5.5 Molecular Partners Recent Development
12.6 Yooyoung Pharm
12.6.1 Yooyoung Pharm Hepatocyte Growth Factor Corporation Information
12.6.2 Yooyoung Pharm Hepatocyte Growth Factor Business Overview and Total Revenue
12.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Yooyoung Pharm Hepatocyte Growth Factor Products Offered
12.6.5 Yooyoung Pharm Recent Development
12.7 F-star
12.7.1 F-star Hepatocyte Growth Factor Corporation Information
12.7.2 F-star Hepatocyte Growth Factor Business Overview and Total Revenue
12.7.3 F-star Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.7.4 F-star Hepatocyte Growth Factor Products Offered
12.7.5 F-star Recent Development
12.8 Galaxy Biotech
12.8.1 Galaxy Biotech Hepatocyte Growth Factor Corporation Information
12.8.2 Galaxy Biotech Hepatocyte Growth Factor Business Overview and Total Revenue
12.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Galaxy Biotech Hepatocyte Growth Factor Products Offered
12.8.5 Galaxy Biotech Recent Development
12.9 Kringle Pharma
12.9.1 Kringle Pharma Hepatocyte Growth Factor Corporation Information
12.9.2 Kringle Pharma Hepatocyte Growth Factor Business Overview and Total Revenue
12.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kringle Pharma Hepatocyte Growth Factor Products Offered
12.9.5 Kringle Pharma Recent Development
13 Hepatocyte Growth Factor Manufacturing Cost Analysis
13.1 Hepatocyte Growth Factor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatocyte Growth Factor
13.4 Hepatocyte Growth Factor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatocyte Growth Factor Distributors List
14.3 Hepatocyte Growth Factor Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hepatocyte Growth Factor Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Hepatocyte Growth Factor Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hepatocyte Growth Factor Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hepatocyte Growth Factor Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hepatocyte Growth Factor Players to Combat Covid-19 Impact
Table 8. Global Market Hepatocyte Growth Factor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hepatocyte Growth Factor Sales (K Units) by Region (2015-2020)
Table 10. Global Hepatocyte Growth Factor Sales Market Share by Region (2015-2020)
Table 11. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hepatocyte Growth Factor Revenue Share by Region (2015-2020)
Table 13. Global Hepatocyte Growth Factor Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Hepatocyte Growth Factor Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hepatocyte Growth Factor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hepatocyte Growth Factor Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hepatocyte Growth Factor (K Units) of Key Companies (2015-2020)
Table 18. Global Hepatocyte Growth Factor Sales Share by Company (2015-2020)
Table 19. Global Hepatocyte Growth Factor Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hepatocyte Growth Factor Revenue Share by Company (2015-2020)
Table 21. Global Hepatocyte Growth Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatocyte Growth Factor as of 2019)
Table 22. Global Hepatocyte Growth Factor Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Hepatocyte Growth Factor Manufacturing Sites and Area Served
Table 24. Manufacturers Hepatocyte Growth Factor Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hepatocyte Growth Factor Players
Table 27. Global Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 28. Global Hepatocyte Growth Factor Sales Share by Type (2015-2020)
Table 29. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hepatocyte Growth Factor Price (K Units) by Type (2015-2020)
Table 31. Global Hepatocyte Growth Factor Sales Share by Type (2021-2026)
Table 32. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hepatocyte Growth Factor Revenue Share by Type (2021-2026)
Table 34. Global Hepatocyte Growth Factor Price (K Units) by Type (2021-2026)
Table 35. Global Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 36. Global Hepatocyte Growth Factor Sales Share by Application (2015-2020)
Table 37. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hepatocyte Growth Factor Price (K Units) by Application (2015-2020)
Table 39. Global Hepatocyte Growth Factor Sales (K Units) by Application (2021-2026)
Table 40. Global Hepatocyte Growth Factor Sales Share by Application (2021-2026)
Table 41. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hepatocyte Growth Factor Revenue Share by Application (2021-2026)
Table 43. Global Hepatocyte Growth Factor Price (K Units) by Application (2021-2026)
Table 44. United States Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 45. United States Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 46. United States Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 47. United States Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 48. United States Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 49. United States Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 50. Europe Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 51. Europe Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 52. Europe Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 53. Europe Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 54. Europe Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 55. Europe Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 56. China Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 57. China Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 58. China Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 59. China Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 60. China Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 61. China Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 62. Japan Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 63. Japan Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 64. Japan Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 65. Japan Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 66. Japan Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 67. Japan Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 74. India Hepatocyte Growth Factor Sales (K Units) by Company (2015-2020)
Table 75. India Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 76. India Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 77. India Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 78. India Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 79. India Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 80. ViroMed Corporation Information
Table 81. ViroMed Description and Business Overview
Table 82. ViroMed Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. ViroMed Hepatocyte Growth Factor Product
Table 84. ViroMed Recent Development
Table 85. AnGes MG Corporation Information
Table 86. AnGes MG Description and Business Overview
Table 87. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AnGes MG Hepatocyte Growth Factor Product
Table 89. AnGes MG Recent Development
Table 90. M3 Biotechnology Corporation Information
Table 91. M3 Biotechnology Description and Business Overview
Table 92. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. M3 Biotechnology Hepatocyte Growth Factor Product
Table 94. M3 Biotechnology Recent Development
Table 95. AVEO Pharmaceuticals Corporation Information
Table 96. AVEO Pharmaceuticals Description and Business Overview
Table 97. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AVEO Pharmaceuticals Hepatocyte Growth Factor Product
Table 99. AVEO Pharmaceuticals Recent Development
Table 100. Molecular Partners Corporation Information
Table 101. Molecular Partners Description and Business Overview
Table 102. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Molecular Partners Hepatocyte Growth Factor Product
Table 104. Molecular Partners Recent Development
Table 105. Yooyoung Pharm Corporation Information
Table 106. Yooyoung Pharm Description and Business Overview
Table 107. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Yooyoung Pharm Hepatocyte Growth Factor Product
Table 109. Yooyoung Pharm Recent Development
Table 110. F-star Corporation Information
Table 111. F-star Description and Business Overview
Table 112. F-star Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. F-star Hepatocyte Growth Factor Product
Table 114. F-star Recent Development
Table 115. Galaxy Biotech Corporation Information
Table 116. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Galaxy Biotech Description and Business Overview
Table 118. Galaxy Biotech Hepatocyte Growth Factor Product
Table 119. Galaxy Biotech Recent Development
Table . Kringle Pharma Corporation Information
Table . Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Kringle Pharma Description and Business Overview
Table . Kringle Pharma Hepatocyte Growth Factor Product
Table . Kringle Pharma Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Hepatocyte Growth Factor Distributors List
Table 128. Hepatocyte Growth Factor Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatocyte Growth Factor Product Picture
Figure 2. Global Hepatocyte Growth Factor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hepatocyte Growth Factor Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiovascular Examples
Figure 8. Central Nervous System Examples
Figure 9. Hematological Disorders Examples
Figure 10. Others Examples
Figure 11. Global Hepatocyte Growth Factor Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Hepatocyte Growth Factor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Hepatocyte Growth Factor Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Hepatocyte Growth Factor Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Hepatocyte Growth Factor Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Hepatocyte Growth Factor Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Hepatocyte Growth Factor Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Hepatocyte Growth Factor Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Hepatocyte Growth Factor Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Hepatocyte Growth Factor Players Market Share by Revenue in Hepatocyte Growth Factor 2015 & 2019
Figure 29. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Hepatocyte Growth Factor Revenue Share by Type (2015-2020)
Figure 31. Global Hepatocyte Growth Factor Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Hepatocyte Growth Factor Revenue Share by Application (2015-2020)
Figure 33. Global Hepatocyte Growth Factor Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 35. United States Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 36. Europe Hepatocyte Growth Factor Sales Market Share by Company in 2019
Figure 37. Europe Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 38. Europe Hepatocyte Growth Factor Sales Market Share by Application in 2019
Figure 39. China Hepatocyte Growth Factor Sales Market Share by Company in 2019
Figure 40. China Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 41. China Hepatocyte Growth Factor Sales Market Share by Application in 2019
Figure 42. Japan Hepatocyte Growth Factor Sales Market Share by Company in 2019
Figure 43. Japan Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 44. Japan Hepatocyte Growth Factor Sales Market Share by Application in 2019
Figure 45. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Company in 2019
Figure 46. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 47. Southeast Asia Hepatocyte Growth Factor Sales Market Share by Application in 2019
Figure 48. India Hepatocyte Growth Factor Sales Market Share by Company in 2019
Figure 49. India Hepatocyte Growth Factor Sales Market Share by Type in 2019
Figure 50. India Hepatocyte Growth Factor Sales Market Share by Application in 2019
Figure 51. ViroMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AnGes MG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. M3 Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AVEO Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Molecular Partners Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Yooyoung Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. F-star Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Galaxy Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Kringle Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Hepatocyte Growth Factor
Figure 62. Manufacturing Process Analysis of Hepatocyte Growth Factor
Figure 63. Hepatocyte Growth Factor Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
結合組織成長因子の世界市場レポート2020 Market Analysis and Insights: Global Connective Tissue Growth Factor Market The global Connective Tissue Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Connective Tissue Growth Factor Scope…- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…
- 凝固因子IXの世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor IX Market The global Coagulation Factor IX market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Coagulation Factor IX Scope and Market Size The global Co…
- 上皮成長因子（EGF）の世界市場レポート2020 A recently published report by QY Research titled Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also sta…
- 凝固因子濃縮物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Coagulation Factor Concentrate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation Fa…